Atricure Inc. buy Needham & Company LLC
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€38.70
Performance (%)
-8.50%
Price
18.02.26
€27.40
Summary
This prediction is currently active. With a performance of -8.50%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 30.04.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | - | - |
| iShares Core DAX® | 0,19 % | -1,22 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % |
| iShares S&P 500 | -1,01 % | -3,40 % |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $51.00 to $44.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat